Assessing a psychological intervention for refugees and asylum seekers

Boosting Refugee Integration Through Psychological Intervention (BRIGHT) - a Pilot Randomised Controlled Trial

NA · University of Zurich · NCT06397105

This study is testing a new mental health support program for refugees and asylum seekers to see if it helps them manage stress and feel better.

Quick facts

PhaseNA
Study typeInterventional
Enrollment40 (estimated)
Ages16 Years and up
SexAll
SponsorUniversity of Zurich (other)
Locations1 site (Zurich)
Trial IDNCT06397105 on ClinicalTrials.gov

What this trial studies

This pilot study evaluates the feasibility and acceptability of an adapted version of the Problem Management Plus (PM+) intervention for refugees and asylum seekers facing psychological distress. PM+ is a brief, low-intensity psychological intervention designed to be delivered by non-professionals, focusing on problem-solving, stress management, behavioral activation, and social support. The study aims to enhance access to mental health care for this vulnerable population by providing additional booster sessions and a digital support program. The findings will inform the design of a larger definitive randomized controlled trial.

Who should consider this trial

Good fit: Ideal candidates include refugees and asylum seekers aged 16 or older who are experiencing moderate to high levels of psychological distress.

Not a fit: Patients with significant cognitive or neurological impairments may not benefit from this intervention.

Why it matters

Potential benefit: If successful, this intervention could significantly improve mental health outcomes for refugees and asylum seekers by providing accessible psychological support.

How similar studies have performed: Previous studies have shown PM+ to be effective in reducing mental health problems in crisis-affected populations, indicating a promising approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* refugees and asylum seekers (RAS) aged 16 or older;
* residing in one of the participating local sites (Swiss municipalities, namely, Gemeinden, and transitional asylum centers, namely, Durchgangszentren) where PM+ is offered and which gave their consent for participation in the RCT;
* speaking at least one of the following 12 languages: German, English, French, Arabic, Farsi, Kurdish, Tigrinya, Turkish, Ukrainian, Russian, Tamil, and Pashto;
* obtaining a score of 20 or higher on the Kessler Psychological Distress Scale (K10; Kessler et al., 2002), a brief clinically validated screening questionnaire that assesses general psychological distress in the past 30 days. A score equal to or higher than 20 is used as an indication of moderate to high levels of psychological distress.

Exclusion Criteria:

* significant cognitive or neurological impairment measured through specific tools developed by the WHO and integrated into the PM+ manual (impairment questionnaire);
* acute medical conditions or severe mental disorders (e.g., psychotic or substance-abuse disorders) measured through specific tools developed by the WHO and integrated into the PM+ manual (impairment questionnaire);
* acute risk of suicide as measured by the Suicidal Ideation Attribution Scale (SIDAS; van Spijker et al., 2014) and the Thoughts of Suicide Questionnaire (World Health Organization WHO, 2016).

Where this trial is running

Zurich

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Psychological Distress, PTSD, Trauma, Psychological, Problem Management Plus, Mental Health Care, Refugees

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.